Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 69 entries
Sorted by: Best Match Show Resources per page
Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure.

Nutrition & metabolism

Li M, Li C, Liu Y, Chen Y, Wu X, Yu D, Werth VP, Williams KJ, Liu ML.
PMID: 26075006
Nutr Metab (Lond). 2015 May 09;12:15. doi: 10.1186/s12986-015-0011-8. eCollection 2015.

BACKGROUND: Cigarette smoking is associated with an increased risk of type 2 diabetes mellitus (T2DM). Smokers exhibit low circulating levels of total adiponectin (ADPN) and high-molecular-weight (HMW) ADPN multimers. Blood concentrations of HMW ADPN multimers closely correlate with insulin...

Cite
Li M, Li C, Liu Y, et al. Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure. Nutr Metab (Lond). 2015;12:15doi: 10.1186/s12986-015-0011-8.
Li, M., Li, C., Liu, Y., Chen, Y., Wu, X., Yu, D., Werth, V. P., Williams, K. J., & Liu, M. L. (2015). Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure. Nutrition & metabolism, 1215. https://doi.org/10.1186/s12986-015-0011-8
Li, Mingzhen, et al. "Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure." Nutrition & metabolism vol. 12 (2015): 15. doi: https://doi.org/10.1186/s12986-015-0011-8
Li M, Li C, Liu Y, Chen Y, Wu X, Yu D, Werth VP, Williams KJ, Liu ML. Decreased secretion of adiponectin through its intracellular accumulation in adipose tissue during tobacco smoke exposure. Nutr Metab (Lond). 2015 May 09;12:15. doi: 10.1186/s12986-015-0011-8. eCollection 2015. PMID: 26075006; PMCID: PMC4465313.
Copy Download .nbib Format: NLM
[Immediate Results of Mitral Valve Surgery in Asymptomatic Patients With Severe Mitral Regurgitation Due to Degenerative Mitral Valve Disease].

Kardiologiia

Nazarov VM, Afanasyev AV, Zheleznev SI, Bogachev-Prokophiev AV, Demin II, Karaskov AM.
PMID: 28294720
Kardiologiia. 2015 Nov;55(11):53-60.

Degenerative mitral valve disease nowadays is the most common cause of mitral insufficiency in developed countries and is associated with high morbidity and mortality. In the last decades repairing the mitral valve has become the operation of choice for...

Cite
Nazarov VM, Afanasyev AV, Zheleznev SI, et al. [Immediate Results of Mitral Valve Surgery in Asymptomatic Patients With Severe Mitral Regurgitation Due to Degenerative Mitral Valve Disease]. Kardiologiia. 2015;55(11):53-60
Nazarov, V. M., Afanasyev, A. V., Zheleznev, S. I., Bogachev-Prokophiev, A. V., Demin, I. I., & Karaskov, A. M. (2015). [Immediate Results of Mitral Valve Surgery in Asymptomatic Patients With Severe Mitral Regurgitation Due to Degenerative Mitral Valve Disease]. Kardiologiia, 55(11), 53-60.
Nazarov, V M, et al. "[Immediate Results of Mitral Valve Surgery in Asymptomatic Patients With Severe Mitral Regurgitation Due to Degenerative Mitral Valve Disease]." Kardiologiia vol. 55,11 (2015): 53-60.
Nazarov VM, Afanasyev AV, Zheleznev SI, Bogachev-Prokophiev AV, Demin II, Karaskov AM. [Immediate Results of Mitral Valve Surgery in Asymptomatic Patients With Severe Mitral Regurgitation Due to Degenerative Mitral Valve Disease]. Kardiologiia. 2015 Nov;55(11):53-60. Russian. PMID: 28294720.
Copy Download .nbib Format: NLM
What are the alternatives to replace the pulmonary root in the absence of pulmonary homografts?.

Annals of cardiothoracic surgery

Sharifulin R, Demin I, Karaskov A, Chernyavsky A, Bogachev-Prokophiev A.
PMID: 34422568
Ann Cardiothorac Surg. 2021 Jul;10(4):524-526. doi: 10.21037/acs-2020-rp-18.

No abstract available.

Cite
Sharifulin R, Demin I, Karaskov A, et al. What are the alternatives to replace the pulmonary root in the absence of pulmonary homografts?. Ann Cardiothorac Surg. 2021;10(4):524-526doi: 10.21037/acs-2020-rp-18.
Sharifulin, R., Demin, I., Karaskov, A., Chernyavsky, A., & Bogachev-Prokophiev, A. (2021). What are the alternatives to replace the pulmonary root in the absence of pulmonary homografts?. Annals of cardiothoracic surgery, 10(4), 524-526. https://doi.org/10.21037/acs-2020-rp-18
Sharifulin, Ravil, et al. "What are the alternatives to replace the pulmonary root in the absence of pulmonary homografts?." Annals of cardiothoracic surgery vol. 10,4 (2021): 524-526. doi: https://doi.org/10.21037/acs-2020-rp-18
Sharifulin R, Demin I, Karaskov A, Chernyavsky A, Bogachev-Prokophiev A. What are the alternatives to replace the pulmonary root in the absence of pulmonary homografts?. Ann Cardiothorac Surg. 2021 Jul;10(4):524-526. doi: 10.21037/acs-2020-rp-18. PMID: 34422568; PMCID: PMC8339624.
Copy Download .nbib Format: NLM
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress.

Diabetes research and clinical practice

Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D.
PMID: 34863716
Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02.

AIMS: Cardiac microvascular dysfunction is a common feature across cardiovascular complications in diabetes, while effective therapy remains elusive. This study was designed to evaluate the effect of irisin on cardiac microvascular injury in type 2 diabetes mellitus (T2DM).METHODS: T2DM...

Cite
Zhu D, Zhang X, Wang F, et al. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021;183:109170doi: 10.1016/j.diabres.2021.109170.
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C., & Liu, D. (2021). Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes research and clinical practice, 183109170. https://doi.org/10.1016/j.diabres.2021.109170
Zhu, Di, et al. "Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress." Diabetes research and clinical practice vol. 183 (2021): 109170. doi: https://doi.org/10.1016/j.diabres.2021.109170
Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02. PMID: 34863716.
Copy Download .nbib Format: NLM
Specific Features of Reactive Pulsed Laser Deposition of Solid Lubricating Nanocomposite Mo-S-C-H Thin-Film Coatings.

Nanomaterials (Basel, Switzerland)

Fominski V, Fominski D, Romanov R, Gritskevich M, Demin M, Shvets P, Maksimova K, Goikhman A.
PMID: 33302538
Nanomaterials (Basel). 2020 Dec 08;10(12). doi: 10.3390/nano10122456.

This work investigates the structure and chemical states of thin-film coatings obtained by pulsed laser codeposition of Mo and C in a reactive gas (H

Cite
Fominski V, Fominski D, Romanov R, et al. Specific Features of Reactive Pulsed Laser Deposition of Solid Lubricating Nanocomposite Mo-S-C-H Thin-Film Coatings. Nanomaterials (Basel). 2020;10(12)doi: 10.3390/nano10122456.
Fominski, V., Fominski, D., Romanov, R., Gritskevich, M., Demin, M., Shvets, P., Maksimova, K., & Goikhman, A. (2020). Specific Features of Reactive Pulsed Laser Deposition of Solid Lubricating Nanocomposite Mo-S-C-H Thin-Film Coatings. Nanomaterials (Basel, Switzerland), 10(12), . https://doi.org/10.3390/nano10122456
Fominski, Vyacheslav, et al. "Specific Features of Reactive Pulsed Laser Deposition of Solid Lubricating Nanocomposite Mo-S-C-H Thin-Film Coatings." Nanomaterials (Basel, Switzerland) vol. 10,12 (2020). doi: https://doi.org/10.3390/nano10122456
Fominski V, Fominski D, Romanov R, Gritskevich M, Demin M, Shvets P, Maksimova K, Goikhman A. Specific Features of Reactive Pulsed Laser Deposition of Solid Lubricating Nanocomposite Mo-S-C-H Thin-Film Coatings. Nanomaterials (Basel). 2020 Dec 08;10(12). doi: 10.3390/nano10122456. PMID: 33302538; PMCID: PMC7764125.
Copy Download .nbib Format: NLM
Performance and Mechanism of Photoelectrocatalytic Activity of MoS.

Nanomaterials (Basel, Switzerland)

Fominski V, Romanov R, Fominski D, Soloviev A, Rubinkovskaya O, Demin M, Maksimova K, Shvets P, Goikhman A.
PMID: 32365935
Nanomaterials (Basel). 2020 Apr 30;10(5). doi: 10.3390/nano10050871.

This work studies the factors that affect the efficiency of the photoelectrochemical hydrogen evolution reaction (HER) using MoS

Cite
Fominski V, Romanov R, Fominski D, et al. Performance and Mechanism of Photoelectrocatalytic Activity of MoS. Nanomaterials (Basel). 2020;10(5)doi: 10.3390/nano10050871.
Fominski, V., Romanov, R., Fominski, D., Soloviev, A., Rubinkovskaya, O., Demin, M., Maksimova, K., Shvets, P., & Goikhman, A. (2020). Performance and Mechanism of Photoelectrocatalytic Activity of MoS. Nanomaterials (Basel, Switzerland), 10(5), . https://doi.org/10.3390/nano10050871
Fominski, Vyacheslav, et al. "Performance and Mechanism of Photoelectrocatalytic Activity of MoS." Nanomaterials (Basel, Switzerland) vol. 10,5 (2020). doi: https://doi.org/10.3390/nano10050871
Fominski V, Romanov R, Fominski D, Soloviev A, Rubinkovskaya O, Demin M, Maksimova K, Shvets P, Goikhman A. Performance and Mechanism of Photoelectrocatalytic Activity of MoS. Nanomaterials (Basel). 2020 Apr 30;10(5). doi: 10.3390/nano10050871. PMID: 32365935; PMCID: PMC7279322.
Copy Download .nbib Format: NLM
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress.

Diabetes research and clinical practice

Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D.
PMID: 34863716
Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02.

AIMS: Cardiac microvascular dysfunction is a common feature across cardiovascular complications in diabetes, while effective therapy remains elusive. This study was designed to evaluate the effect of irisin on cardiac microvascular injury in type 2 diabetes mellitus (T2DM).METHODS: T2DM...

Cite
Zhu D, Zhang X, Wang F, et al. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021;183:109170doi: 10.1016/j.diabres.2021.109170.
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C., & Liu, D. (2021). Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes research and clinical practice, 183109170. https://doi.org/10.1016/j.diabres.2021.109170
Zhu, Di, et al. "Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress." Diabetes research and clinical practice vol. 183 (2021): 109170. doi: https://doi.org/10.1016/j.diabres.2021.109170
Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02. PMID: 34863716.
Copy Download .nbib Format: NLM
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress.

Diabetes research and clinical practice

Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D.
PMID: 34863716
Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02.

AIMS: Cardiac microvascular dysfunction is a common feature across cardiovascular complications in diabetes, while effective therapy remains elusive. This study was designed to evaluate the effect of irisin on cardiac microvascular injury in type 2 diabetes mellitus (T2DM).METHODS: T2DM...

Cite
Zhu D, Zhang X, Wang F, et al. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021;183:109170doi: 10.1016/j.diabres.2021.109170.
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C., & Liu, D. (2021). Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes research and clinical practice, 183109170. https://doi.org/10.1016/j.diabres.2021.109170
Zhu, Di, et al. "Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress." Diabetes research and clinical practice vol. 183 (2021): 109170. doi: https://doi.org/10.1016/j.diabres.2021.109170
Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02. PMID: 34863716.
Copy Download .nbib Format: NLM
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress.

Diabetes research and clinical practice

Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D.
PMID: 34863716
Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02.

AIMS: Cardiac microvascular dysfunction is a common feature across cardiovascular complications in diabetes, while effective therapy remains elusive. This study was designed to evaluate the effect of irisin on cardiac microvascular injury in type 2 diabetes mellitus (T2DM).METHODS: T2DM...

Cite
Zhu D, Zhang X, Wang F, et al. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021;183:109170doi: 10.1016/j.diabres.2021.109170.
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C., & Liu, D. (2021). Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes research and clinical practice, 183109170. https://doi.org/10.1016/j.diabres.2021.109170
Zhu, Di, et al. "Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress." Diabetes research and clinical practice vol. 183 (2021): 109170. doi: https://doi.org/10.1016/j.diabres.2021.109170
Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02. PMID: 34863716.
Copy Download .nbib Format: NLM
Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Schmitt EK, Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Su G, Csermak Renner K, Venishetty VK, Sayyed S, Straimer J, Demin I, Barsainya S, Boulton C, Gandhi P.
PMID: 34410358
Clin Infect Dis. 2021 Aug 19; doi: 10.1093/cid/ciab716. Epub 2021 Aug 19.

BACKGROUND: Cipargamin (KAE609) is a potent antimalarial in Phase II. Here we report efficacy, pharmacokinetics, and resistance marker analysis across a range of cipargamin doses. These were secondary endpoints from a study primarily conducted to assess the hepatic safety...

Cite
Schmitt EK, Ndayisaba G, Yeka A, et al. Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab716.
Schmitt, E. K., Ndayisaba, G., Yeka, A., Asante, K. P., Grobusch, M. P., Karita, E., Mugerwa, H., Asiimwe, S., Oduro, A., Fofana, B., Doumbia, S., Su, G., Csermak Renner, K., Venishetty, V. K., Sayyed, S., Straimer, J., Demin, I., Barsainya, S., Boulton, C., & Gandhi, P. (2021). Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab716
Schmitt, Esther K, et al. "Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab716
Schmitt EK, Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Su G, Csermak Renner K, Venishetty VK, Sayyed S, Straimer J, Demin I, Barsainya S, Boulton C, Gandhi P. Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria. Clin Infect Dis. 2021 Aug 19; doi: 10.1093/cid/ciab716. Epub 2021 Aug 19. PMID: 34410358.
Copy Download .nbib Format: NLM
Reward-based, task-setting education strategy on glycemic control and self-management for low-income outpatients with type 2 diabetes.

Journal of diabetes investigation

Guo H, Tian X, Li R, Lin J, Jin N, Wu Z, Yu D.
PMID: 25411600
J Diabetes Investig. 2014 Jul;5(4):410-7. doi: 10.1111/jdi.12152. Epub 2013 Oct 18.

AIMS/INTRODUCTION: The purpose of the study was to determine the feasibility and effect of a reward-based, task-setting strategy for low-income outpatients with type 2 diabetes.MATERIALS AND METHODS: Indigent diabetes outpatients without glucometers were eligible to participate in this trial....

Cite
Guo H, Tian X, Li R, et al. Reward-based, task-setting education strategy on glycemic control and self-management for low-income outpatients with type 2 diabetes. J Diabetes Investig. 2013;5(4):410-7doi: 10.1111/jdi.12152.
Guo, H., Tian, X., Li, R., Lin, J., Jin, N., Wu, Z., & Yu, D. (2014). Reward-based, task-setting education strategy on glycemic control and self-management for low-income outpatients with type 2 diabetes. Journal of diabetes investigation, 5(4), 410-7. https://doi.org/10.1111/jdi.12152
Guo, Honglei, et al. "Reward-based, task-setting education strategy on glycemic control and self-management for low-income outpatients with type 2 diabetes." Journal of diabetes investigation vol. 5,4 (2014): 410-7. doi: https://doi.org/10.1111/jdi.12152
Guo H, Tian X, Li R, Lin J, Jin N, Wu Z, Yu D. Reward-based, task-setting education strategy on glycemic control and self-management for low-income outpatients with type 2 diabetes. J Diabetes Investig. 2014 Jul;5(4):410-7. doi: 10.1111/jdi.12152. Epub 2013 Oct 18. PMID: 25411600; PMCID: PMC4210071.
Copy Download .nbib Format: NLM
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress.

Diabetes research and clinical practice

Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D.
PMID: 34863716
Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02.

AIMS: Cardiac microvascular dysfunction is a common feature across cardiovascular complications in diabetes, while effective therapy remains elusive. This study was designed to evaluate the effect of irisin on cardiac microvascular injury in type 2 diabetes mellitus (T2DM).METHODS: T2DM...

Cite
Zhu D, Zhang X, Wang F, et al. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021;183:109170doi: 10.1016/j.diabres.2021.109170.
Zhu, D., Zhang, X., Wang, F., Ye, Q., Yang, C., & Liu, D. (2021). Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes research and clinical practice, 183109170. https://doi.org/10.1016/j.diabres.2021.109170
Zhu, Di, et al. "Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress." Diabetes research and clinical practice vol. 183 (2021): 109170. doi: https://doi.org/10.1016/j.diabres.2021.109170
Zhu D, Zhang X, Wang F, Ye Q, Yang C, Liu D. Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress. Diabetes Res Clin Pract. 2021 Dec 02;183:109170. doi: 10.1016/j.diabres.2021.109170. Epub 2021 Dec 02. PMID: 34863716.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 69 entries